EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy

Jongjin Kim iD, Juan Francisco Morales iD, Sanghoon Kang iD, Marian Klose iD, Rebecca J Willcocks iD, Michael J Daniels iD, Ramona Belfiore-Oshan iD, Glenn A Walter iD, William D Rooney iD, Krista Vandenborne iD, Sarah Kim iD

CPT: Pharmacometrics & Systems Pharmacology · 2025-11 · 14 (11) · 1765-1774

DOI: 10.1002/psp4.13246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 03.10.2024. Verfasst von Jongjin Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Computer Simulation, User-Computer Interface, Clinical Trials as Topic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, National Institutes of Health (NIH) National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative model‐based clinical trial simulation tools play a critical role in informing study designs through simulation before actual execution. These tools help drug developers explore various trial scenarios in silico to select a clinical trial design to detect therapeutic effects more efficiently, therefore reducing time, expense, and participants' burden. To increase the usability of the tools, user‐friendly and interactive platforms should be developed to navigate various simulation scenarios. However, developing such tools challenges researchers, requiring expertise in modeling and interface development. This tutorial aims to address this gap by guiding developers in creating tailored R Shiny apps, using an example of a model‐based clinical trial simulation tool that we developed for Duchenne muscular dystrophy (DMD). In this tutorial, the structural framework, essential controllers, and visualization techniques for analysis are described, along with key code examples such as criteria selection and power calculation. A virtual population was created using a machine learning algorithm to enlarge the available sample size to simulate clinical trial scenarios in the presented tool. In addition, external validation of the simulated outputs was conducted using a placebo arm of a recently published DMD trial. This tutorial will be particularly useful for developing clinical trial simulation tools based on DMD progression models for other end points and biomarkers. The presented strategies can also be applied to other diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneComputer SimulationUser-Computer InterfaceClinical Trials as TopicHumansResearch DesignMachine LearningAlgorithms

Autor:innen und Institutionen

  • Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
  • Department of Statistics and Data Science, University of Central Florida, Orlando, Florida, USA.
  • Department of Physical Therapy, University of Florida, Gainesville, Florida, USA.
  • Department of Statistics, University of Florida, Gainesville, Florida, USA.
  • Critical Path Institute, Tucson, Arizona, USA.
  • Department of Physiology and Aging, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Jongjin Kim, Juan Francisco Morales, Sanghoon Kang, Marian Klose, Rebecca J Willcocks, Michael J Daniels, Ramona Belfiore-Oshan, Glenn A Walter, William D Rooney, Krista Vandenborne, Sarah Kim

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health (NIH) National Center for Advancing Translational Sciences
  • NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases & NIH National Institute of Neurological Disorders and Stroke

Zitieren

APA

Kim, J., Morales, J. F., Kang, S., Klose, M., Willcocks, R. J., Daniels, M. J., Belfiore-Oshan, R., Walter, G. A., Rooney, W. D., Vandenborne, K., & Kim, S. (2025). A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy. CPT: Pharmacometrics & Systems Pharmacology, 14(11), 1765-1774. https://doi.org/10.1002/psp4.13246

Vancouver

Kim J, Morales JF, Kang S, Klose M, Willcocks RJ, Daniels MJ, et al. A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy. CPT: Pharmacometrics & Systems Pharmacology. 2025;14(11):1765-1774. doi:10.1002/psp4.13246

BibTeX
@article{Kim2025,
  author = {Kim, Jongjin and Morales, Juan Francisco and Kang, Sanghoon and Klose, Marian and Willcocks, Rebecca J and Daniels, Michael J and Belfiore-Oshan, Ramona and Walter, Glenn A and Rooney, William D and Vandenborne, Krista and Kim, Sarah},
  title = {A model‐informed clinical trial simulation tool with a graphical user interface for Duchenne muscular dystrophy},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  volume = {14},
  number = {11},
  pages = {1765--1774},
  doi = {10.1002/psp4.13246}
}
Kostenlos starten →